BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England
- PMID: 2045751
- PMCID: PMC1060707
- DOI: 10.1136/jech.45.1.78
BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England
Abstract
Study objective: The aim was to assess the protection conferred by BCG given during the first year of life against tuberculosis among children of Asian ethnic origin born in England.
Design: This was a matched case-control study.
Setting: Cases were selected from notifications of tuberculosis and controls were selected from child health or school health records in 14 English health districts.
Participants: 111 cases of childhood tuberculosis with Asian names were selected. For each case there were five controls with Asian names, matched for age, sex and district of birth.
Measurements and main results: Child health or school health records were searched to determine the proportions of cases and controls who had been vaccinated with BCG. Overall, BCG vaccination given in the first year of life was estimated to confer 49% protection against tuberculosis with 95% confidence interval 14-62%.
Conclusions: BCG vaccination in infancy was found to be associated with a lower protective efficacy than has been found for the secondary school age BCG programme (80%) but nevertheless the protection is substantial and, in the United Kingdom, BCG vaccination of infants considered to be at relatively higher risk of tuberculosis is likely to reduce the incidence of childhood tuberculosis.
Similar articles
-
Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.Int J Epidemiol. 1995 Oct;24(5):1042-9. doi: 10.1093/ije/24.5.1042. Int J Epidemiol. 1995. PMID: 8557438
-
Protective effect of BCG vaccination in infant Asians: a case-control study.Arch Dis Child. 1988 Mar;63(3):277-81. doi: 10.1136/adc.63.3.277. Arch Dis Child. 1988. PMID: 3258499 Free PMC article.
-
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.Health Technol Assess. 2017 Jul;21(39):1-54. doi: 10.3310/hta21390. Health Technol Assess. 2017. PMID: 28738015 Free PMC article.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Bacillus Calmette-Guérin vaccination at birth: Effects on early childhood infections, growth, and development.Dan Med J. 2016 Nov;63(11):B5304. Dan Med J. 2016. PMID: 27808041 Review.
Cited by
-
Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society.Thorax. 2000 Nov;55(11):887-901. doi: 10.1136/thorax.55.11.887. Thorax. 2000. PMID: 11050256 Free PMC article. Review.
-
Urban-rural differences in immune responses to mycobacterial and tetanus vaccine antigens in a tropical setting: A role for helminths?Parasitol Int. 2020 Oct;78:102132. doi: 10.1016/j.parint.2020.102132. Epub 2020 May 5. Parasitol Int. 2020. PMID: 32387542 Free PMC article.
-
Does BCG have a role in tuberculosis control and prevention in the United Kingdom?Arch Dis Child. 2006 Jun;91(6):529-31. doi: 10.1136/adc.2005.085043. Arch Dis Child. 2006. PMID: 16714729 Free PMC article. Review.
-
Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.Infect Immun. 2000 May;68(5):2888-98. doi: 10.1128/IAI.68.5.2888-2898.2000. Infect Immun. 2000. PMID: 10768986 Free PMC article.
-
TB in Leicester: out of control, or just one of those things?BMJ. 2001 May 12;322(7295):1133-4. doi: 10.1136/bmj.322.7295.1133. BMJ. 2001. PMID: 11348891 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical